6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (S1P) receptor for the treatment of multiple sclerosis

Details for Australian Patent Application No. 2008285722 (hide)

Owner Merck Serono S.A.

Inventors Crosignani, Stefano; Schwarz, Matthias; Bombrun, Agnes; Covini, David; Marin, Delphine

Agent FB Rice

Pub. Number AU-A-2008285722

PCT Pub. Number WO2009/019167

Priority 60/964,864 15.08.07 US; 07113992.7 08.08.07 EP

Filing date 29 July 2008

Wipo publication date 12 February 2009

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/02 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/019167 Priority application(s): WO2009/019167

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285729-Benzoyl-piperidine derivatives as dual modulators of the 5-HT2a and D3 receptors

2008285718-Pyrrolidine aryl-ether as NK3 receptor antagonists